Skip to main content
OpenTrials
Completed

NCT Number: NCT02939053

Correlation of SOZO BIS Measures With CardioMEMS PA Pressure

This study aims to establish the degree to which change in the ratio of ECF to TBW measured using the SOZO BIS device correlates with change in end-expiratory end-diastolic PAP measured using the CardioMEMS HF System (St. Jude Medical).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic, Rochester, Minnesota, United States

Loading trial locations.

About this study

This is a prospective, single-arm, observational, non-randomized clinical study that will enroll patients with heart failure who have had a CardioMEMS™ device implanted to monitor their diastolic pulmonary artery pressure. The study will recruit and enroll thirty participants. Participants will be monitored daily at home for a period of 30 days. Each day, the patient's diastolic pulmonary artery pressure will be measured by CardioMEMS™ and the ImpediMed's BIS technology. Participant's weight will also be taken each day.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older.
  • NYHA Class III HF.
  • Patient has undergone implantation of CardioMEMS HF System (St. Jude Medical).
  • Patient is characterized by at least one of the following:
  • CardioMEMS implanted within the previous 90 days
  • Received treatment with intravenous diuretics within the previous 30 days
  • Received dose escalation of oral diuretics at least twice within the previous 30 days
  • Patient is able to sit upright for BIS measurements.
  • Patient provides written informed consent and authorization to use and disclose health information.

Exclusion criteria

  • Patient is enrolled in a concurrent interventional study of an experimental treatment that may confound the results of this study, in the investigator's opinion.
  • Patient has a clinical condition that would not allow them to complete the study.
  • Patient is pregnant or lactating.
  • Patient has nephrotic syndrome or nephrosis.
  • Patient has estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2 or end-stage renal disease requiring chronic dialysis.
  • Patient has been diagnosed with lymphedema.
  • Patient has chronic liver failure or cirrhosis.
  • Patient has a moderate or large pleural effusion as seen on chest X-ray.
  • Patient has been diagnosed with thrombophlebitis or deep vein thrombosis in arms or legs in the past 90 days.
  • Patient has an implanted cardiac rhythm management device (pacemaker or implantable cardioverter defibrillator).
  • Patient has an amputation of a limb.

Treatment and study plan

SOZO

Device

The SOZO device is a bioimpedance spectroscopy device that measures bioimpedance parameters.

Primary outcomes

  1. Change in the ratio of whole body ECF/TBW measured using the SOZO BIS device

    Time frame: From baseline through study completion, an average of 30 days

    Changes of body fluid levels in heart failure patients

Secondary outcomes

  1. Change in the ratio of thoracic ECF/TBW

    Time frame: From baseline through study completion, an average of 30 days

    Changes of thoracic fluid levels in heart failure patients

  2. Change in the ratio of lower extremity ECF/TBW

    Time frame: From baseline through study completion, an average of 30 days

    Changes of lower limb fluid levels in heart failure patients

Sponsors and collaborators

Lead sponsor

ImpediMed Limited

Industry

Collaborators

  • Baim Institute for Clinical Research
  • Scripps Health

Registry information

Official study title

Correlation of Bioimpedance Measurements From the SOZO Device With Pulmonary Arterial Pressure Measurements From the CardioMEMS HF System

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
Oct 19, 2016
Registry last updated
Jul 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.